STRATEGIC HEALTHCARE INDUSTRY UPDATES ON AMAZON, BOEHRINGER INGELHEIM, MERCK AND OTHER GLOBAL HEALTHCARE ENTERPRISES
by John G. Baresky on 12/23/20
October, November and December
have been exceptionally active months spanning multiple sectors in the
healthcare industry. Get the new strategic updates on these and other
healthcare enterprises by clicking here now!
- Amazon (Nasdaq: AMZN) Unveils “Care Hub”: A New Alexa Healthcare Service
- Boehringer Ingelheim Acquiring NBE Therapeutics For $1.5 Billion
- FDA Approves Eiger Biopharmaceuticals (NASDAQ: EIGR) New Product Zokinvy (lonafarnib)
- New Genentech (Roche - OTC: RHHBY) Oncology Drug Gavreto (pralsetinib) Approved By FDA
- Lucira Health: FDA Approves First At-Home COVID-19 Test
- Merck (NYSE: MRK) Announces $2.75 Billion Acquisition of VelosBio
- Orladeyo (Berotralstat) By Biocryst Pharmaceuticals (NASDAQ: BSX) Earns FDA Approval
- Rite Aid (NYSE: RAD) Acquires Bartell Drugs
- Royal Philips Nv (NYSE: PHG) Acquires BioTelemetry (NASDAQ: BEAT) For $2.5 Billion
- Select Rehabilitation Is Acquiring Kindred Healthcare's (Humana - NYSE: HUM) RehabCare Business Unit
- UPMC And CarePathRx Form Partnership In $400 Million Deal
Comments (0)